Cardiovascular risk assessment after anti-TNF treatment in patients with rheumatoid arthritis and ankylosing spondylitis with Strain Echocardiography
- 1 December 2022
- journal article
- research article
- Published by Galenos Yayinevi in Ulusal Romatoloji Dergisi
- Vol. 14 (3) , 117-123
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiographyInternational Journal of Cardiology, 2012
- Cardiovascular risk factors in inflammatory arthritisCurrent Opinion in Lipidology, 2011
- Association of serum markers with improvement in clinical response measures after treatment with golimumab in patients with active rheumatoid arthritis despite receiving methotrexate: results from the GO-FORWARD studyArthritis Research & Therapy, 2010
- Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actionsAnnals of the Rheumatic Diseases, 2009
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?Arthritis & Rheumatism, 2008
- Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007
- Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF- antagonistsRheumatology, 2007
- Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2006
- High prevalence of metabolic syndrome in patients with ankylosing spondylitisClinical Rheumatology, 2006
- Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid ArthritisCirculation, 2003